These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 27486010)

  • 1. NAFLD and liver transplantation: Current burden and expected challenges.
    Pais R; Barritt AS; Calmus Y; Scatton O; Runge T; Lebray P; Poynard T; Ratziu V; Conti F
    J Hepatol; 2016 Dec; 65(6):1245-1257. PubMed ID: 27486010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic Fatty Liver Disease: Key Considerations Before and After Liver Transplantation.
    Patel YA; Berg CL; Moylan CA
    Dig Dis Sci; 2016 May; 61(5):1406-16. PubMed ID: 26815171
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-alcoholic fatty liver disease and liver transplantation: outcomes and advances.
    Said A
    World J Gastroenterol; 2013 Dec; 19(48):9146-55. PubMed ID: 24409043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic steatohepatitis: the new frontier for liver transplantation.
    Bzowej NH
    Curr Opin Organ Transplant; 2018 Apr; 23(2):169-174. PubMed ID: 29356708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: Implications for Liver Transplantation.
    Younossi ZM; Marchesini G; Pinto-Cortez H; Petta S
    Transplantation; 2019 Jan; 103(1):22-27. PubMed ID: 30335697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-and-post transplant considerations in patients with nonalcoholic fatty liver disease.
    Khullar V; Dolganiuc A; Firpi RJ
    World J Transplant; 2014 Jun; 4(2):81-92. PubMed ID: 25032097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
    Bertot LC; Adams LA
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes of liver transplantation for non-alcoholic steatohepatitis: A European Liver Transplant Registry study.
    Haldar D; Kern B; Hodson J; Armstrong MJ; Adam R; Berlakovich G; Fritz J; Feurstein B; Popp W; Karam V; Muiesan P; O'Grady J; Jamieson N; Wigmore SJ; Pirenne J; Malek-Hosseini SA; Hidalgo E; Tokat Y; Paul A; Pratschke J; Bartels M; Trunecka P; Settmacher U; Pinzani M; Duvoux C; Newsome PN; Schneeberger S;
    J Hepatol; 2019 Aug; 71(2):313-322. PubMed ID: 31071367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic factors affecting hepatocellular carcinoma in steatohepatitis.
    Zarrinpar A; Faltermeier CM; Agopian VG; Naini BV; Harlander-Locke MP; Kaldas FM; Farmer DG; Busuttil RW
    Liver Int; 2019 Mar; 39(3):531-539. PubMed ID: 30427105
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changing trends of liver transplantation and mortality from non-alcoholic fatty liver disease.
    Majumdar A; Tsochatzis EA
    Metabolism; 2020 Oct; 111S():154291. PubMed ID: 32531295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
    Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
    J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical epidemiology and disease burden of nonalcoholic fatty liver disease.
    Perumpail BJ; Khan MA; Yoo ER; Cholankeril G; Kim D; Ahmed A
    World J Gastroenterol; 2017 Dec; 23(47):8263-8276. PubMed ID: 29307986
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver transplantation for non-alcoholic fatty liver disease: indications and post-transplant management.
    Battistella S; D'Arcangelo F; Grasso M; Zanetto A; Gambato M; Germani G; Senzolo M; Russo FP; Burra P
    Clin Mol Hepatol; 2023 Feb; 29(Suppl):S286-S301. PubMed ID: 36577425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation and non-alcoholic fatty liver disease.
    Zezos P; Renner EL
    World J Gastroenterol; 2014 Nov; 20(42):15532-8. PubMed ID: 25400437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries.
    Holmer M; Melum E; Isoniemi H; Ericzon BG; Castedal M; Nordin A; Aagaard Schultz N; Rasmussen A; Line PD; Stål P; Bennet W; Hagström H
    Liver Int; 2018 Nov; 38(11):2082-2090. PubMed ID: 29630771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease and hepatocellular carcinoma: Clinical challenges of an intriguing link.
    Chrysavgis L; Giannakodimos I; Diamantopoulou P; Cholongitas E
    World J Gastroenterol; 2022 Jan; 28(3):310-331. PubMed ID: 35110952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease and liver transplantation - Where do we stand?
    Mikolasevic I; Filipec-Kanizaj T; Mijic M; Jakopcic I; Milic S; Hrstic I; Sobocan N; Stimac D; Burra P
    World J Gastroenterol; 2018 Apr; 24(14):1491-1506. PubMed ID: 29662288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nash Up, Virus Down: How the Waiting List Is Changing for Liver Transplantation: A Single Center Experience from Italy.
    Ferrarese A; Battistella S; Germani G; Russo FP; Senzolo M; Gambato M; Vitale A; Cillo U; Burra P
    Medicina (Kaunas); 2022 Feb; 58(2):. PubMed ID: 35208613
    [No Abstract]   [Full Text] [Related]  

  • 19. How will NAFLD change the liver transplant landscape in the 2020s?
    Villeret F; Dumortier J; Erard-Poinsot D
    Clin Res Hepatol Gastroenterol; 2022 Jan; 46(1):101759. PubMed ID: 34311133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease.
    Degasperi E; Colombo M
    Lancet Gastroenterol Hepatol; 2016 Oct; 1(2):156-164. PubMed ID: 28404072
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.